Table 3.
Vaccines approved for children immunization worldwide.
| Country | Vaccine | Date of Approval for Children (5–11 Years of Age) |
Agency | Beginning of Child Immunization |
References |
|---|---|---|---|---|---|
| United States | BNT162b2 (Pfizer and BioNTech) |
29 October 2021 | FDA | 2 November 2022 | [180] |
| Brazil | BNT162b2 (Pfizer and BioNTech) |
16 December 2021 | Anvisa | 14 January 2022 | [181,182] |
| CoronaVac (Sinovac) |
20 January 2022 | ||||
| Canada | BNT162b2 (Pfizer and BioNTech) |
19 November 2021 | Health Canada | 23 November 2021 | [183] |
| China | Covilo (Sinopharm Beijing) |
8 June 2021 (For 3–11 years of age) |
NMPA | 25 October 2021 | [184,185] |
| Vero Cells (Sinopharm Wuhan) | |||||
| CoronaVac (Sinovac) |
August 2021 | ||||
| Israel | BNT162b2 (Pfizer and BioNTech) |
14 November 2021 | Health Ministry | 22 November 2021 | [186] |
| Australia | BNT162b2 (Pfizer and BioNTech) |
5 December 2021 | TGA | 10 January 2022 | [187] |
| Italy | BNT162b2 (Pfizer and BioNTech) |
1 December 2021 | AIFA | 16 December 2021 | [188] |
| Japan | BNT162b2 (Pfizer and BioNTech) |
31 January 2022 | Japan’s Health Ministry | Forecast to February end or early March 2022 | [189] |
| United Kingdom | BNT162b2 (Pfizer and BioNTech) |
22 December 2021 (Vulnerable children) 16 February 2022 (All children) |
MHRA | End of January 2022 (vulnerable children) Forecast to mid-April 2022 (All children) |
[190] |
| Chile | CoronaVac (Sinovac) |
6 September 2021 (For 6–12 years of age) |
ISP | 6 December 2021 | [191] |
AIFA—Agenzia Italiana del Farmaco; Anvisa—Brazilian Health Regulatory Agency; FDA—US Food and Drug Administration; ISP—Instituto de Salud Publica; MHRA—UK Medicines and Healthcare products Regulatory Agency; NMPA—National Medical Products Administration; TGA—Therapeutic Goods Administration.